threat
influenza
infect
felt
global
diseas
lead
estim
million
case
sever
ill
death
year
although
strategi
antagon
influenza
infect
vaccin
partial
success
necess
effect
antivir
agent
underscor
toxic
side
effect
current
avail
drug
emerg
drugresist
variant
influenza
virus
like
virus
oblig
intracellular
pathogen
exploit
host
cellular
machineri
replic
identif
cellular
mechan
requir
viru
life
cycl
shed
light
traffick
characterist
also
provid
strategi
interf
host
factor
altern
approach
inhibit
viral
infect
elucid
hostpathogen
interact
unbias
approach
gain
insight
diseas
pathogenesi
receiv
ampl
attent
variou
function
assay
system
use
screen
host
factor
involv
influenza
viru
replic
cycl
thu
far
rna
interfer
rnai
base
genomewid
screen
strategi
drosophila
mammalian
system
approach
includ
proteom
yeast
twohybrid
analys
microarray
extens
inform
acquir
multipl
cellular
network
implic
influenza
viru
replic
either
direct
proteinprotein
interact
signal
pathway
although
strategi
unveil
hundr
gene
import
viru
life
cycl
function
relev
molecular
mechan
still
poorli
understood
among
other
approach
effort
invest
dissect
cellular
interactor
viral
ribonucleoprotein
complex
regul
replic
transcript
influenza
viru
host
interactor
nonstructur
protein
multifunct
protein
modul
sever
aspect
viru
replic
cycl
major
role
inhibit
interferon
mediat
immun
respons
also
extens
studi
howev
littl
attent
drawn
identifi
cellular
factor
associ
viral
matrix
protein
reason
integr
membran
protein
viral
envelop
would
interact
cellular
factor
variou
stage
endosom
fusion
releas
genet
materi
entri
transport
endoplasm
reticulum
plasma
membran
assembl
bud
nascent
virion
minor
protein
viral
envelop
form
homotetram
nativ
state
interestingli
possess
longest
ctermin
tail
among
three
viral
envelop
protein
name
hemagglutinin
ha
neuraminidas
ion
channel
initi
discov
target
antivir
drug
amantadin
facilit
diffus
proton
interior
endosom
entrap
viru
low
ph
induc
conform
chang
ha
subsequ
trigger
fusion
endosom
membran
viru
entri
singlepass
membran
protein
display
consider
pleiotrop
determin
filament
morpholog
viral
strain
bind
cholesterol
cytoplasm
tail
ct
interact
site
viru
bud
effici
packag
viru
particl
rossman
et
al
report
role
mediat
cholesteroldepend
alter
membran
curvatur
neck
bud
virion
lead
host
escrt
pathwayindepend
membran
scission
altogeth
studi
provid
evid
influenza
especi
ct
domain
play
critic
role
multipl
step
viru
life
cycl
henc
identif
cellular
interactor
would
provid
mechanist
insight
influenza
pathogenesi
possibl
develop
novel
strategi
interfer
multipl
step
infect
process
use
bait
screen
human
placenta
complementari
dna
cdna
librari
identifi
host
protein
either
facilit
restrict
viral
infect
cyclin
key
regul
cell
cycl
phase
progress
uncov
novel
host
factor
interact
physic
interact
cyclin
confirm
virusinfect
cell
influenza
viru
iav
infect
result
host
cell
cycl
arrest
phase
accompani
cyclin
reloc
degrad
use
combin
small
interf
rna
sirna
mediat
genet
analys
show
cyclin
restrict
iav
product
independ
role
cell
cycl
restrict
cyclin
iav
life
cycl
impair
viral
protein
synthesi
interf
bind
may
result
defect
assembl
releas
progeni
virion
role
cyclin
context
influenza
infect
describ
previous
interestingli
result
suggest
novel
function
cyclin
beyond
classic
function
cell
cycl
regul
iav
ion
channel
protein
multifunct
protein
highli
conserv
sequenc
among
influenza
viru
isol
approach
ident
region
among
three
viral
envelop
protein
possess
longest
ct
high
probabl
interact
cellular
machineri
variou
step
viru
life
cycl
includ
fusion
intracellular
traffick
secretori
pathway
viru
assembl
bud
plasma
membran
consider
interest
identifi
intracellular
interactor
elucid
cellular
compon
exploit
influenza
also
understand
host
defens
involv
restrict
viru
life
cycl
end
randomprim
cdna
librari
human
placenta
screen
use
iav
bait
fig
screen
reveal
human
cyclin
genbanktm
access
number
one
promin
interactor
summar
tabl
sequenc
align
posit
clone
point
amino
acid
residu
minim
interact
domain
fig
domain
cyclin
larg
outsid
cyclin
box
respons
bind
activ
cyclindepend
kinas
also
region
greatest
homolog
occur
among
dtype
cyclin
find
togeth
absenc
cyclin
among
posit
clone
suggest
certain
degre
specif
interact
test
next
seri
experi
cyclin
form
complex
function
regulatori
subunit
cyclindepend
kinas
whose
activ
requir
cell
cycl
earli
phase
three
earli
phase
dtype
cyclin
function
relat
tissuespecif
express
profil
result
screen
indic
cyclin
two
dtype
cyclin
interact
first
check
specif
interact
human
lung
epitheli
cell
fusion
protein
purifi
incub
wildtyp
cell
lysat
pull
endogen
dtype
cyclin
cyclin
bound
specif
either
gst
bead
fig
altogeth
result
confirm
cyclin
bind
iav
examin
intracellular
associ
cyclin
iav
life
cycl
coimmunoprecipit
experi
perform
virusinfect
cell
hek
cell
transient
transfect
plasmid
encod
flagtag
cyclin
cyclin
infect
influenza
viru
cell
lysat
immunoprecipit
antiflag
antibodi
immunoblot
antibodi
shown
fig
lane
found
copurifi
cyclin
demonstr
physic
interact
viru
infect
either
directli
common
interactor
interact
observ
control
sampl
cell
either
mocktransfect
immunoprecipit
antiflag
antibodi
fig
lane
transfect
cyclin
immunoprecipit
isotyp
control
antibodi
fig
lane
data
valid
cyclin
bona
fide
interactor
influenza
corrobor
result
screen
specif
interact
cyclin
test
use
panel
exogen
express
cyclin
cyclin
although
appear
interact
cyclin
degre
overexpress
consist
found
strongest
interact
cyclin
fig
understand
function
relev
cyclin
interact
virusinfect
cell
test
subcellular
distribut
immunofluoresc
imag
achiev
unbias
analysi
cell
infect
influenza
viru
moi
mix
popul
infect
uninfect
cell
sampl
cell
fix
h
postinfect
pi
stain
cyclin
protein
uninfect
cell
cyclin
resid
nucleu
cytoplasm
nuclear
complex
display
retinoblastoma
rb
direct
kinas
activ
interestingli
upon
viru
infect
much
weaker
cyclin
signal
observ
nuclei
infect
cell
compar
control
cell
reveal
stain
result
suggest
cyclin
redistribut
nucleu
cytosol
respons
infect
fig
top
panel
effect
protein
cyclin
reloc
recapitul
analog
experi
use
cell
express
protein
alon
fig
bottom
panel
result
appar
reduct
cyclin
nucleu
similar
phenotyp
induc
viral
infect
address
reduct
cyclin
nucleu
upon
viru
infect
fraction
control
infect
cell
cytosol
nuclear
materi
measur
cyclin
level
cytoplasm
nucleusenrich
extract
prepar
moi
achiev
homogen
infect
cell
cultur
uninfect
cell
lamin
gapdh
use
marker
verifi
clear
separ
nuclear
cytoplasm
fraction
total
intracellular
level
cyclin
virusinfect
cell
decreas
observ
mockinfect
cell
fig
b
c
top
densitometr
analysi
indic
total
cyclin
found
nucleu
uninfect
cell
like
underestim
cyclin
solubl
would
leak
nuclear
cytoplasm
fraction
experiment
procedur
percentag
nuclear
cyclin
drop
h
pi
fig
bottom
indic
transloc
cyclin
nucleu
cytoplasm
virusinfect
cell
signific
reduct
nuclear
cyclin
detect
biochem
measur
confirm
immunofluoresc
data
subcellular
reloc
verifi
coloc
cyclin
infect
cyclin
cell
h
pi
cyclin
degrad
select
earlier
time
point
treat
mock
virusinfect
cell
increas
signal
strength
cyclin
inde
h
pi
could
captur
coloc
influenza
cyclin
along
secretori
pathway
fig
cyclin
appear
cytosol
fraction
condit
interact
cyclin
combin
enrich
cytosol
upon
express
strongli
suggest
associ
must
occur
cytosol
either
directli
complex
presum
en
rout
assembl
releas
intact
progeni
virion
induct
dtype
cyclin
growth
factordepend
mrna
protein
exhibit
moder
oscil
continu
prolifer
cell
popul
given
decreas
total
intracellular
cyclin
level
observ
virusinfect
cell
next
address
whether
influenza
viru
modul
cyclin
protein
level
addit
alter
subcellular
local
express
profil
cyclin
anoth
cell
cycl
phase
regul
cyclin
e
measur
immunoblot
cyclin
dramat
downregul
iav
infect
almost
undetect
level
compar
uninfect
cell
h
pi
fig
top
time
cours
analysi
reveal
steadyst
level
cyclin
start
declin
h
pi
decreas
h
pi
fig
bottom
cyclin
e
activ
late
stage
cell
cycl
phase
facilit
transit
display
moder
reduct
ident
condit
fig
contrari
find
et
al
cyclin
e
vastli
downregul
iav
infect
howev
quantit
analysi
provid
studi
prevent
us
compar
reduct
level
worth
note
cyclin
e
exist
multipl
protein
rang
size
mr
tumor
cell
line
illustr
other
see
also
fig
howev
one
band
size
cyclin
e
shown
studi
although
cell
type
use
differenti
regul
cyclin
cyclin
e
indic
iav
infect
specif
deregul
compon
earli
phase
phase
cell
cycl
machineri
investig
mechan
virusinduc
cyclin
downregul
determin
involv
proteasom
degrad
pathway
process
cell
infect
viru
absenc
presenc
proteasom
inhibitor
test
cyclin
level
also
known
calpain
inhibitor
inhibit
proteasom
calpain
activ
calpain
calciumdepend
proteas
produc
limit
proteolysi
substrat
result
fragment
degrad
proteolyt
pathway
includ
proteasom
calpain
report
regul
cyclin
posttranscript
level
proteasom
inhibitor
prevent
degrad
ubiquitinconjug
protein
uninfect
cell
treat
drug
control
baselin
oscil
cyclin
level
proteasom
inhibit
affect
cyclin
abund
uninfect
cell
howev
block
proteasom
activ
led
signific
stabil
cyclin
virusinfect
cell
treatment
block
cyclin
degrad
respect
compar
vehicl
control
dmso
treat
group
measur
densitometr
analysi
immunoblot
fig
thu
obviou
rescu
cyclin
observ
one
round
infect
h
pi
use
proteasom
inhibitor
regul
cell
cycl
moder
also
investig
although
viral
infect
also
result
cyclin
downregul
protein
level
fig
level
downregul
robust
cyclin
protein
level
could
rescu
proteas
calpain
inhibitor
compar
cyclin
fig
find
suggest
iav
post
cyclin
effect
infect
data
indic
iav
infect
result
reduc
cyclin
level
nucleu
virusinfect
cell
phenotyp
trigger
transloc
nuclear
cyclin
cytoplasm
iav
facilit
proteasom
degrad
cytoplasm
cyclin
princip
role
dtype
cyclin
act
growth
factor
sensor
convert
environment
signal
fuel
cell
cycl
engin
interact
cyclin
viral
life
cycl
impli
potenti
regul
host
cell
cycl
iav
support
observ
cyclin
activ
remov
nucleu
degrad
proteasom
virusinfect
cell
address
whether
cell
cycl
compromis
quantit
profil
cell
cycl
kinet
perform
virusinfect
cell
use
asynchron
grow
cell
popul
found
virusinfect
cell
accumul
phase
compar
uninfect
group
data
shown
reduc
variabl
due
mix
popul
cell
differenti
phase
cell
cycl
first
synchron
infect
use
lovastatin
fungal
metabolit
shown
affect
cell
cycl
distribut
revers
manner
cell
releas
lovastatin
block
stimul
mevalon
time
infect
trigger
progress
later
cell
cycl
stage
brdu
incorpor
dna
content
stain
show
viru
infect
brought
cell
cycl
arrest
h
pi
fig
overlay
cell
cycl
pattern
virusinfect
uninfect
cell
indic
infect
decreas
peak
repres
cell
phase
fig
percentag
cell
phase
exhibit
progress
timedepend
drop
subsequ
h
pi
respect
mean
sd
three
experi
mockinfect
sampl
reduct
reflect
progress
cell
phase
follow
entri
later
stage
cell
cycl
contrast
cell
infect
viru
remain
percentag
cell
phase
hover
time
point
fig
result
demonstr
iav
infect
impair
progress
cell
cycl
intersect
prove
iav
infect
induc
cell
cycl
arrest
phase
use
separ
approach
cell
preaccumul
phase
treatment
inhibitor
h
pi
control
sampl
compar
percentag
cell
phase
cell
cycl
fig
similar
result
obtain
lovastatin
cell
cycl
pattern
virusinfect
cell
show
lower
peak
phase
compar
uninfect
cell
fig
upon
recoveri
cell
drug
restrict
uninfect
infect
cell
resum
divis
initi
new
round
cell
cycl
display
increas
percentag
cell
repres
phase
h
pi
uninfect
cell
howev
progress
phase
percentag
cell
phase
drop
around
control
sampl
wherea
remain
constant
iavinfect
cell
fig
collect
result
indic
iav
infect
perturb
normal
cell
cycl
progress
human
cell
line
instal
block
phase
dtype
cyclin
activ
initi
phosphoryl
rb
multipl
site
hyperphosphoryl
rb
pprb
releas
transcript
factor
lead
activ
transcript
cell
cycl
progressionrespons
gene
test
whether
iavinduc
cell
cycl
arrest
impos
rb
phosphoryl
statu
rb
monitor
phosphoryl
serin
pprb
specif
catalyz
cyclin
complex
cyclin
surprisingli
iav
infect
progress
result
diminish
level
pprb
function
time
fig
furthermor
serin
phosphoryl
rb
pprb
affect
phase
cell
cycl
display
similar
trend
fig
observ
consist
virusinduc
block
phase
line
downregul
pprb
protein
accumul
hypophosphoryl
rb
prb
observ
fig
inhibit
cell
cycl
also
occur
induct
cyclindepend
kinas
inhibitor
cki
univers
cki
inhibit
cyclin
cdk
subunit
instal
phase
arrest
interestingli
upon
infect
downregul
proteasom
degrad
indic
iavinduc
arrest
mediat
pathway
fig
b
express
level
famili
cki
specif
inhibit
catalyt
subunit
also
measur
increas
observ
even
prolong
infect
time
data
shown
result
describ
conclud
iav
infect
downregul
cyclin
level
turn
inhibit
activ
ultim
result
reduc
rb
phosphoryl
consequ
prb
sequest
transcript
factor
prevent
cell
cycl
entri
phase
establish
function
relev
cyclin
iav
pathogenesi
studi
effect
knockdown
viru
replic
avoid
offtarget
effect
impos
use
sirna
pool
use
individu
sirna
duplex
publish
literatur
gener
knockdown
sirna
effect
reduc
endogen
cyclin
express
level
h
posttransfect
compar
nonspecif
control
sirna
nontarget
nt
fig
control
nt
sirnatr
cyclin
cell
infect
moi
allow
multipl
round
infect
viral
titer
obtain
cyclin
cell
least
greater
control
cell
fig
left
cyclin
interact
identifi
use
avian
measur
effect
knockdown
replic
highli
pathogen
avian
influenza
viru
observ
higher
progeni
viru
product
cyclin
cell
compar
control
group
h
pi
fig
right
differ
product
viru
less
signific
h
pi
like
due
cytopath
effect
viru
limit
cell
cultur
system
differenti
whether
increas
progeni
viru
titer
intrins
absenc
cyclin
protein
consequ
cell
cycl
arrest
induc
cyclin
silenc
next
use
combin
sirna
target
variou
step
cell
cycl
modul
progress
concomit
knockdown
rescu
cell
phase
block
impos
cyclin
defici
allow
us
measur
effect
cyclin
alon
viru
replic
addit
includ
knockdown
induc
cell
cycl
arrest
interfac
without
affect
cyclin
level
gain
confid
specif
cyclin
sirna
includ
second
sirna
duplex
specif
cyclin
individu
sirna
sirna
combin
result
signific
reduct
desir
gene
express
fig
control
sirnatr
cell
popul
around
cell
found
phase
cell
cycl
expect
knockdown
alon
arrest
cell
cycl
progress
cell
cell
phase
compar
cell
treat
nt
sirna
concomit
knockdown
rescu
cell
cycl
progress
phase
knockdown
express
cell
induc
robust
cell
cycl
phase
accumul
knockdown
cell
phase
fig
sirnamedi
knockdown
cell
subject
infect
viru
moi
h
posttransfect
progeni
viru
product
knockdown
two
individu
sirna
duplex
increas
progeni
viru
titer
approxim
log
despit
rescu
cell
cycl
progress
doubl
knockdown
normal
viru
product
compar
nt
sirnatr
cell
differ
viral
titer
persist
control
cell
harbor
doubl
knockdown
viru
titer
cell
knockdown
compar
doubl
knockdown
fig
left
studi
whether
inhibitori
role
cyclin
viral
replic
also
applic
iav
strain
two
clinic
isol
test
h
pi
equival
higher
viru
titer
influenza
virus
confirm
result
fig
middl
right
panel
examin
distribut
dtype
cyclin
context
natur
infect
determin
express
human
airway
particular
human
bronchial
epitheli
cell
hbec
pneumocyt
although
cyclin
mrna
express
lower
level
compar
two
dtype
cyclin
cell
type
fig
compar
protein
amount
cyclin
detect
hbec
pneumocyt
fig
cyclin
express
could
detect
two
primari
cell
fig
collect
cyclin
express
tissu
along
natur
infect
rout
iav
valid
function
relev
cell
perform
knockdown
cyclin
hbec
studi
effect
influenza
viru
product
observ
cell
cyclin
defici
hbec
result
increas
viral
titer
support
conclus
experi
perform
activ
divid
cell
fig
c
understand
mode
cyclin
restrict
iav
product
first
measur
whether
viral
protein
synthesi
affect
cyclin
separ
effect
cyclin
defici
cell
cycl
arrest
use
doubl
knockdown
multipl
time
point
select
measur
viral
protein
synthesi
within
singl
cycl
infect
knockdown
cell
display
enhanc
viral
protein
synthesi
compar
control
cell
fig
suggest
effect
cyclin
iav
infect
probabl
occur
later
step
viral
protein
translat
biogenesi
viral
particl
involv
proper
packag
assembl
viral
protein
rna
form
intact
virion
discret
bud
site
multifunct
protein
cytosol
tail
interact
promot
recruit
viral
intern
protein
vrna
plasma
membran
effici
viru
assembl
postul
bind
cyclin
might
affect
interact
result
attenu
viru
releas
due
either
product
defect
viru
particl
due
improp
packag
ii
incomplet
assembl
virion
henc
gener
fewer
particl
test
hypothesi
hek
cell
cotransfect
cyclin
cell
express
without
exogen
cyclin
use
control
condit
bind
detect
coimmunoprecipit
follow
immunoblot
fig
left
lane
upon
overexpress
cyclin
level
coprecipit
significantli
lower
amount
obtain
absenc
cyclin
fig
left
lane
densitometr
analysi
reveal
reduct
bind
observ
cyclin
overexpress
fig
right
isotyp
control
antibodi
use
parallel
bind
fig
left
lane
result
demonstr
cyclin
affect
viral
protein
synthesi
iav
life
cycl
ii
interact
significantli
attenu
presenc
cyclin
propos
competit
bind
cyclin
restrict
iav
product
either
reduc
defect
progeni
virion
format
test
hypothesi
cyclin
cell
control
cell
infect
measur
plasma
membran
express
viral
protein
within
one
cycl
infect
illustr
fig
detect
plasma
membran
cyclin
cell
suggest
without
blockag
impos
cyclin
greater
amount
could
reach
cell
surfac
andor
faster
pace
thu
facilit
recruit
viral
intern
compon
plasma
membran
assembl
bud
trend
could
observ
time
interv
summar
fig
addit
could
valid
result
use
confoc
imag
overexpress
cyclin
result
predominantli
confin
earli
secretori
network
compar
control
cell
endogen
cyclin
level
signific
fraction
appear
plasma
membran
fig
interestingli
although
absenc
cyclin
weak
interactor
facilit
iav
progeni
viru
product
effect
occur
differ
mechan
surfac
express
remain
unaffect
cell
deplet
cyclin
data
shown
search
interactom
protein
iav
host
cell
limit
far
host
protein
shown
exploit
includ
nakatpas
heat
shock
protein
inhibitor
protein
kinas
addit
amphipath
helix
locat
within
bind
cholesterol
alter
local
membran
curvatur
bud
zone
provid
scaffold
polymer
filament
elong
withdraw
cholesterol
disrupt
amphipath
helix
inhibit
viral
filament
format
previous
identifi
annexin
novel
interactor
impair
bud
releas
iav
late
stage
viru
life
cycl
recent
found
interact
famili
ubiquitinrel
protein
resid
autophagosom
membran
highli
conserv
region
promot
bind
reloc
plasma
membran
mechan
allow
subvers
autophagi
facilit
interorgan
viral
transmiss
enhanc
stabil
progeni
virion
present
studi
identifi
cyclin
novel
interactor
systemat
studi
role
context
iav
infect
key
regul
cell
cycl
progress
knockdown
default
lead
cell
cycl
phase
arrest
provid
favor
environ
iav
replic
result
indic
cyclin
function
beyond
role
cell
cycl
context
influenza
infect
absenc
cyclin
combin
accumul
cell
cycl
phase
appear
addit
effect
iav
progeni
viru
product
indic
cyclin
defici
specif
facilit
influenza
viru
product
independ
cell
cycl
instead
coimmunoprecipit
suggest
cyclin
impair
nascent
viru
product
late
stage
viru
life
cycl
interf
bind
fig
result
illustr
yet
anoth
mechan
iav
evolv
counteract
host
defens
cyclin
redistribut
nucleu
cytoplasm
target
proteasom
degrad
inde
misloc
subsequ
downregul
restrict
factor
one
recur
mechan
virus
adopt
overcom
host
defens
presenc
trap
cyclin
cytoplasm
two
possibl
mechan
interact
newli
synthes
cyclin
prevent
transloc
nucleu
ii
cyclin
retain
cytoplasm
nuclear
export
detail
mechan
cyclin
target
proteasom
complex
ubiquityl
pursu
futur
investig
downregul
cyclin
transcript
previous
observ
cell
implic
address
studi
expand
repertoir
host
interactor
propos
novel
function
cyclin
life
cycl
iav
manipul
cell
cycl
machineri
adopt
mani
virus
common
strategi
instanc
accessori
protein
vpr
report
induc
arrest
activ
protein
phosphatas
act
mitosi
inhibitor
kinas
phosphatas
similar
find
viral
protein
found
bind
member
cyclin
famili
persist
infect
borna
diseas
viru
result
reduc
progress
likewis
nucleoprotein
sarscov
inhibit
activ
bind
cyclin
block
phase
progress
viral
protein
associ
particular
cell
cycl
compon
therebi
deregul
host
cell
cycl
clock
alter
environ
effici
replic
remain
determin
whether
interact
inhibit
kinas
activ
iav
infect
cell
cycl
arrest
iav
infect
first
report
et
al
although
phenomenon
investig
mechanist
term
nonstructur
protein
iav
later
discov
interact
inhibit
activ
ra
homolog
gene
famili
member
rhoa
provid
molecular
insight
mechan
iavinduc
cell
cycl
perturb
present
studi
quantit
demonstr
iav
infect
impos
specif
arrest
establish
cyclin
misloc
degrad
follow
interact
underli
molecular
correl
coevolut
adapt
virushost
interact
best
describ
zero
sum
biolog
arm
race
howev
due
high
mutat
rate
virus
influenza
well
equip
rapidli
evolv
strategi
evad
host
restrict
factor
consequ
case
iav
infect
effect
cyclin
success
antagon
redirect
cyclin
nucleu
cytosol
follow
proteasom
degrad
therebi
grant
advantag
viru
product
studi
provid
import
insight
mechan
cyclin
restrict
iav
infect
demonstr
increas
progeni
viru
product
upon
knockdown
result
enhanc
viral
protein
synthesi
host
cell
instead
inhibitori
effect
cyclin
iav
infect
due
interact
viral
protein
measur
competit
coimmunoprecipit
assay
hypothes
cyclin
interact
either
mask
domain
mediat
bind
higher
affin
anoth
possibl
cyclin
interact
sequest
amount
avail
consequ
limit
bind
bud
process
iav
infect
result
fewer
progeni
virion
effici
packag
releas
host
cell
sever
host
factor
identifi
interfer
late
stage
viral
life
cycl
among
tetherin
also
known
best
character
addit
interferonstimul
gene
isg
product
group
newli
emerg
host
restrict
factor
control
viral
bacteri
parasit
infect
exemplifi
viperin
name
current
studi
includ
cyclin
famili
iav
bud
inhibitor
provid
insight
dynam
interplay
cyclin
iav
infect
influenza
viru
genbanktm
access
number
use
bait
screen
interactor
randomprim
human
placenta
cdna
librari
contain
million
independ
fragment
clone
bait
screen
perform
hybrigen
pari
franc
briefli
fuse
lexa
bind
domain
subclon
vector
yeast
strain
transform
bait
plasmid
mate
yeast
strain
transform
prey
librari
clone
select
perform
leucin
tryptophan
histidin
dropout
medium
posit
diploid
pick
identifi
prey
fragment
subject
pcr
sequenc
go
filtrat
divid
contig
sequenc
compar
recent
updat
genbanktm
databas
use
blastn
decod
interact
interact
assign
comput
confid
score
assess
interact
reliabl
human
alveolar
basal
epitheli
human
embryon
kidney
hek
madindarbi
canin
kidney
mdck
cell
purchas
atcc
dulbecco
modifi
eagl
medium
dmem
invitrogen
supplement
fetal
bovin
serum
fb
unitsml
penicillin
streptomycin
invitrogen
use
cultur
maintain
cell
type
use
influenza
viru
strain
propag
mdck
cell
supplement
bovin
serum
albumin
bsa
sigmaaldrich
presenc
tosylphenylalanyl
chloromethyl
keton
tpck
treat
trypsin
thermo
scientif
store
viru
stock
use
viral
titer
obtain
plaqu
assay
mdck
cell
briefli
serial
dilut
viru
stock
adsorb
onto
confluent
monolay
mdck
cell
h
next
viral
inoculum
remov
cell
wash
twice
phosphatebuff
salin
pb
ph
cell
cover
semisolid
agar
dmem
complement
bsa
tpcktreat
trypsin
three
day
incub
plate
upsid
manner
plaqu
visual
stain
crystal
violet
plasmid
gener
subclon
open
read
frame
orf
homo
sapien
genbanktm
access
number
plasmid
origen
technolog
vector
mlui
sgfi
restrict
site
plasmid
rabbit
polyclon
antibodi
pab
kindli
donat
prof
adolfo
icahn
school
medicin
mount
sinai
follow
primari
antibodi
use
studi
mous
anticyclin
monoclon
antibodi
mab
clone
purchas
cell
signal
technolog
mous
anticyclin
e
mab
clone
mous
antiinfluenza
mab
clone
mous
antiinfluenza
mab
clone
rabbit
pab
purchas
santa
cruz
biotechnolog
inc
mous
antiinfluenza
mab
clone
purchas
thermo
scientif
mous
antiflag
mab
clone
mous
anticmyc
mab
clone
purchas
sigmaaldrich
mous
antihuman
prb
mab
clone
mous
antirb
pprb
mab
clone
mous
antirb
pprb
mrb
clone
purchas
bd
bioscienc
rabbit
anticyclin
mab
clone
mous
antiinfluenza
nucleoprotein
mab
clone
mous
antilamin
mab
clone
mous
antigapdh
mab
clone
purchas
abcam
texa
redconjug
goat
antirabbit
igg
hl
pab
fitcconjug
goat
antimous
igg
hl
pab
purchas
life
technolog
inc
dna
fragment
encod
gene
influenza
viru
strain
clone
vector
express
escherichia
coli
strain
result
gst
fusion
protein
purifi
glutathionesepharos
bead
ge
healthcar
ad
cell
lysat
empti
vector
express
gst
alon
use
neg
control
overnight
incub
bead
collect
centrifug
wash
five
time
remov
nonspecif
bind
bound
protein
resolv
sdspage
immunoblot
indic
antibodi
hek
cell
transfect
plasmid
dish
h
posttransfect
cell
infect
influenza
strain
moi
h
lyse
buffer
contain
mm
tri
ph
mm
sodium
chlorid
triton
sodium
deoxychol
mm
edta
proteas
inhibitor
roch
appli
scienc
cell
extract
clear
centrifug
supernat
incub
antiflag
isotyp
control
antibodi
overnight
protein
gsepharos
bead
ge
healthcar
use
recov
immun
complex
whole
cell
lysat
immunoprecipit
sampl
wash
five
time
lysi
buffer
resolv
sdspage
detect
western
blot
interact
specif
studi
perform
hek
cell
transfect
plasmid
encod
one
cmyctag
cyclin
target
similar
treatment
describ
coimmunoprecipit
experi
competit
bind
assay
hek
cell
cotransfect
plasmid
plasmid
cm
dish
bulk
cell
lysat
prepar
describ
h
post
transfect
clear
cell
extract
incub
santa
cruz
isotyp
control
antibodi
overnight
follow
recoveri
immun
complex
whole
cell
lysat
use
protein
gsepharos
bead
immunoprecipit
sampl
wash
six
time
lysi
buffer
resolv
sdspage
detect
western
blot
lovastatin
use
synchron
cell
phase
briefli
cultur
medium
remov
h
initi
plate
cell
replac
fresh
complet
medium
contain
lovastatin
sigmaaldrich
cell
incub
lovastatin
h
achiev
cell
cycl
phase
synchron
experiment
procedur
time
cell
allow
reenter
cell
cycl
progress
replac
medium
fresh
complet
medium
supplement
mm
mevalonolacton
sigmaaldrich
synchron
cell
transit
follow
h
follow
plate
cell
medium
replac
fresh
complet
medium
contain
calbiochem
incub
h
cell
wash
three
time
pb
cultur
fresh
complet
medium
promot
cell
cycl
progress
cell
cycl
profil
analyz
brdu
incorpor
dna
content
stain
briefli
presynchron
cell
infect
moi
influenza
strain
mockinfect
immedi
collect
cell
incub
brdu
invitrogen
h
fix
overnight
ethanol
brdupuls
cell
rescu
ethanol
denatur
hydrochlor
acid
triton
min
room
temperatur
follow
neutral
mm
borat
buffer
ph
brdu
label
reveal
alexa
fluor
brdu
mous
mab
clone
invitrogen
total
dna
content
measur
bd
pharmingen
stain
cell
immedi
analyz
bd
lsr
ii
flow
cytomet
bd
immunocytometri
system
approxim
cell
acquir
sampl
data
analyz
use
flowjo
softwar
treestar
cell
infect
viru
moi
mockinfect
variou
time
point
infect
cell
wash
twice
icecold
pb
lyse
buffer
contain
mm
tri
ph
mm
sodium
chlorid
triton
sodium
deoxychol
mm
edta
proteas
inhibitor
endtoend
rotat
h
facilit
lysi
cell
lysat
clear
centrifug
g
min
whole
cell
lysat
boil
min
sampl
load
dye
mm
dtt
subject
sdspage
block
ubiquitinmedi
protein
degrad
virusinfect
moi
mockinfect
cell
incub
fresh
medium
contain
either
sigmaaldrich
sigmaaldrich
start
infect
dmso
sigmaaldrich
contain
medium
use
vehicl
control
experi
whole
cell
lysat
collect
h
infect
describ
cell
fraction
cell
infect
moi
influenza
viru
h
pi
cell
wash
twice
icecold
pb
lyse
dish
icecold
buffer
contain
mm
tri
ph
mm
magnesium
chlorid
mm
sodium
chlorid
triton
permeabil
cell
collect
rubber
policeman
transfer
eppendorf
tube
brief
incub
supernat
cytoplasmenrich
pellet
nucleusenrich
fraction
separ
upon
centrifug
g
nuclear
fraction
solubil
buffer
contain
mm
tri
ph
mm
magnesium
chlorid
mm
sodium
chlorid
sd
dna
shredder
use
process
nuclear
fraction
shear
genom
dna
easier
sdspolyacrylamid
gel
load
sampl
sampl
load
dye
dtt
final
concentr
mm
respect
ad
lysat
boil
min
captur
subcellular
coloc
influenza
cyclin
cell
transfect
wildtyp
cyclin
plasmid
h
posttransfect
cell
either
mock
virusinfect
moi
cell
maintain
medium
supplement
durat
infect
h
pi
cell
collect
immunofluoresc
assay
determin
effect
cyclin
coloc
influenza
cell
transfect
either
empti
vector
cyclin
h
posttransfect
cell
infect
influenza
moi
h
pi
cell
collect
stain
confoc
imag
influenza
cell
plate
onto
glass
coverslip
day
transfect
infect
cell
wash
pb
fix
paraformaldehyd
min
end
experi
coverslip
incub
mm
ammonium
chlorid
min
quench
autofluoresc
paraformaldehyd
permeabil
pb
contain
triton
min
cyclin
stain
rabbit
anticyclin
mab
follow
incub
fitcconjug
goat
antirabbit
igg
viral
protein
visual
label
mous
mab
follow
stain
texa
redconjug
goat
antimous
igg
viral
protein
visual
label
rabbit
pab
follow
fitcconjug
goat
antirabbit
igg
wash
pb
coverslip
incub
dapi
nucleu
stain
mount
mowiol
glass
slide
imag
acquir
zeiss
lsm
confoc
fluoresc
microscop
faculti
imag
core
facil
univers
hong
kong
genespecif
sirna
purchas
dharmacon
dharmacon
research
individu
sirna
sequenc
sequenc
human
cyclin
transcript
nontarget
sirna
use
sirna
human
cyclin
transcript
human
transcript
provid
sigenom
smartpool
contain
mixtur
four
sirna
target
differ
site
singl
gene
cell
transfect
sirna
final
concentr
mm
gene
use
dharmafect
transfect
reagent
accord
manufactur
protocol
cell
subcultur
h
posttransfect
avoid
potenti
cell
cycl
arrest
induc
overconflu
studi
effect
gene
knockdown
influenza
progeni
viru
product
sirnatr
cell
hbec
infect
influenza
virus
h
seed
moi
dmem
contain
bsa
sigmaaldrich
presenc
tpcktreat
trypsin
thermo
scientif
supernat
collect
h
pi
progeni
viru
titer
obtain
plaqu
assay
describ
separ
well
without
infect
use
determin
knockdown
effici
western
blot
effect
sirna
treatment
influenza
viral
protein
express
investig
cell
prepar
describ
cell
infect
viru
moi
suppli
fresh
cell
cultur
medium
contain
fb
unitsml
penicillin
streptomycin
remov
viru
inoculum
whole
cell
lysat
prepar
individu
well
h
pi
western
blot
analysi
cyclin
sirnatr
control
cell
infect
moi
viru
studi
effect
cyclin
reduct
plasma
membran
express
synchron
viral
entri
cell
incub
viru
h
replac
prewarm
fresh
cell
cultur
medium
virusinfect
cell
collect
fix
h
pi
surfac
express
detect
use
mab
thermo
scientif
follow
fitcconjug
secondari
antibodi
without
permeabil
cell
immedi
analyz
bd
lsr
ii
flow
cytomet
bd
immunocytometri
system
approxim
cell
acquir
sampl
data
analyz
use
flowjo
softwar
treestar
gene
express
pattern
determin
twostep
rtpcr
briefli
total
rna
isol
around
hbec
pneumocyt
use
rneasi
plu
kit
combin
qiashredd
qiagen
cdna
gener
total
rna
use
superscript
iii
firststrand
synthesi
system
invitrogen
accord
manufactur
recommend
cdna
product
use
undilut
hbec
dilut
pneumocyt
serial
dilut
plasmid
cyclin
known
gene
copi
number
use
gener
standard
curv
absolut
quantif
desir
gene
express
realtim
pcr
perform
reaction
contain
fluorigen
taqman
probe
final
concentr
nm
togeth
nm
concentr
primer
probe
master
roch
appli
scienc
assay
perform
lightcycl
ii
roch
appli
scienc
thermal
cycl
condit
min
follow
cycl
min
sampl
quantifi
triplic
experi
primer
probe
follow
forward
revers
fam
ccagagtgatcaagtgtgacccagactgcc
tamra
taqman
probe
cyclin
forward
revers
fam
aagctgtctctgatccgcaagcatgc
tamra
taqman
probe
cyclin
forward
revers
fam
tggcagggatcactggcactgaagtggact
tamra
taqman
probe
cyclin
forward
revers
fam
caaactcaacgtgcaagcctcggat
tamra
taqman
probe
cyclin
result
shown
mean
sd
indic
number
experi
statist
differ
group
determin
unpair
student
test
twoway
anova
signific
level
f
design
perform
analyz
experi
c
k
p
perform
experi
fig
c
w
c
prepar
hbec
pneumocyt
sampl
z
f
k
provid
technic
assist
contribut
prepar
figur
b
n
design
supervis
part
experi
r
b
assist
f
analyz
data
wrote
manuscript
input
author
